Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
News
News Search Submit News Release
Patient
Patient Resources Drug Development
History
NE Life Science History (TM) Genealogy Posters
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 History
 Advertising
 
Learn important smoking facts.
 
Community Service Ad: American Red Cross, Together, we can save a life
 
Facilities
 

EquipNet Auction: Coty’s Aerosol Plant Closure - Feb. 18-28

Washington Life Science Genealogy is setting sail, get on board & sponsor now!

Can't fill a job? Try a free six month job posting trial


Industry News

Genetic Literacy Project - Science Not Ideology

Search Articles: 
  • Opdivo (nivolumab) plus low-dose Yervoy demonstrates continued survival benefit Bristol-Myers Squibb announced new results from the Phase 3 CheckMate -214 study, showing that therapy with Opdivo (nivolumab) plus low-dose Yervoy (ipilimumab) continued to demonstrate long-term survival benefits in patients with previously untreated advanced or metastatic renal cell carcinoma.
    February 11, 2019

More...

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2019 Info.Resource, Inc. All rights reserved.
Privacy Policy & Cookies . Terms of Use . About . Advertising

NebraskaLifeScience.com is owned and published by Info.Resource, Inc.